European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Roche promised that its investments in the U.S. means it will export more medicines than it imports in the U.S.

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK825.00.

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...

Novo Nordisk has an analyst consensus of Hold, with a price target consensus of $84.83. According to TipRanks.com, Walton is ranked #6629 out of 9418 analysts. Sanofi has an analyst consensus of ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...